| ACE2 |
COVID-19 |
H. sapiens |
1 |
115-180 |
2 |
Zhang et al., Nature 2023 |
| CACNA1C |
Schizophrenia |
H. sapiens |
1 |
150 |
0 |
|
| CLU |
Alzheimer Disease |
H. sapiens |
2 |
111 |
2 |
|
| Mole gene |
Mammalian Intersexuality |
T. occidentalis |
1 |
120 |
1 |
|
| Fly TAD |
Transcriptional Regulation |
D. melanogaster |
1 |
100 |
4 |
|
| H19/Igf2 |
Enhancer Selectivity |
M. musculus |
2 |
157 |
47 |
Ordoñez et al., Mol Cell 2024 |
| HBA1 (α-globin) |
Alpha-Thalassemia |
M. musculus |
1 |
90 |
29 |
|
| HoxA (rat) |
Embryonic Development |
R. norvegicus |
11 |
170 |
32 |
Pinglay,Bulajic et al., Science 2022 |
| HoxA (mouse) |
Embryonic Development |
M. musculus |
11 |
170 |
2 |
|
| HPRT1 |
Lesch-Nyhan Syndrome |
H. sapiens |
1 |
101 |
1 |
Mitchell et al., Genetics 2021 |
| HPRT1R |
Genomes default state |
n/a |
1 |
101 |
1 |
Camellato et al., Nature 2024 |
| HTRA1 |
Age-Related Macular Degeneration |
H. sapiens |
2 |
119 |
148+ |
Laurent et al., Precision Clinical Medicine 2019 |
| IRF5 |
Systemic Lupus Erythematosus |
H. sapiens |
1 |
37-104 |
18 |
|
| NKX6-3/ANK1 |
Type 2 Diabetes |
H. sapiens |
2 |
52 |
2 |
|
| Pax6 |
Eye Development |
T. rubripes (Fugu) |
3 |
82 |
0 |
|
| RET |
Hirschsprung Disease |
H. sapiens |
1 |
60-179 |
4 |
|
| Sox2 |
Embryonic Development |
M. Musculus |
1 |
41-142 |
83 |
Brosh, Laurent et al., PNAS 2021; Brosh et al., Mol Cell 2023 |
| Synthetic Locus |
Transcriptional Regulation |
M. Musculus |
n/a |
53-180 |
0 |
|
| TAF1 |
X-linked dystonia-parkinsonism |
H. sapiens |
1 |
77 |
4 |
|
| TMPRSS2 |
COVID-19 |
H. sapiens |
1 |
80 |
1 |
Zhang et al., Nature 2023 |
| Trp53 |
Cancer |
M. musculus |
1 |
22-115 |
5 |
Zhang et al., Nature 2023 |
| TP53 |
Cancer |
H. sapiens |
2 |
47 |
1 |
|
| Xist |
X chromosome inactivation |
M. Musculus |
1 |
25-200 |
5 |
|